On the Alert for Cytokine Storm: Immunopathology in <scp>COVID</scp>‐19

2020648 citationsJournal Articlebronze Open Access

Authors

Lauren A. Henderson · Boston Children's Hospital

Scott Canna · University of Pittsburgh

Grant S. Schulert · Cincinnati Children's Hospital Medical Center

Stefano Volpi · Istituto Giannina Gaslini

Pui Y. Lee · Harvard University

Kate F. Kernan · University of Pittsburgh

Roberto Caricchio

Abstract

Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19.

Topics & Keywords

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research COVID-19 and healthcare impacts

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Arthritis & Rheumatology

Volume 72, Issue 7, pp. 1059-1063

DOI: 10.1002/art.41285

Field-Weighted Citation Impact: 15.25